Zvi Y. Fuks
#149,222
Most Influential Person Now
Zvi Y. Fuks's AcademicInfluence.com Rankings
Download Badge
Physics
Zvi Y. Fuks's Degrees
- PhD Physics Moscow State University
Why Is Zvi Y. Fuks Influential?
(Suggest an Edit or Addition)Zvi Y. Fuks's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. (2000) (946)
- High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. (2002) (831)
- High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. (2001) (726)
- Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. (1999) (622)
- DOSE ESCALATION WITH THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY AFFECTS THE OUTCOME IN PROSTATE CANCER (1998) (616)
- Non‐hodgkin's lymphomas iv. clinicopathologic correlation in 405 cases (1973) (578)
- Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. (2000) (565)
- High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. (2008) (498)
- The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. (1991) (448)
- The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer. (2000) (403)
- Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. (1996) (387)
- Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. (1999) (379)
- Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. (2001) (356)
- Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. (2000) (328)
- Long term tolerance of high dose three‐dimensional conformal radiotherapy in patients with localized prostate carcinoma (1999) (327)
- Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. (2008) (325)
- Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. (1997) (321)
- Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. (2010) (299)
- Clinically relevant optimization of 3-D conformal treatments. (1992) (297)
- Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes. (2008) (284)
- The role of postoperative radiotherapy after resection of single brain metastases. (1989) (270)
- Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. (1999) (248)
- Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease. (1976) (246)
- The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. (1991) (231)
- Comparison of the 5-Year Outcome and Morbidity of Three-Dimensional Conformal Radiotherapy Versus Transperineal Permanent Iodine-125 Implantation for Early-Stage Prostatic Cancer (1999) (216)
- Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. (1997) (207)
- Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. (1997) (206)
- Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer. (2003) (203)
- Electron-beam therapy for mycosis fungoides: the Stanford University experience. (1979) (199)
- Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. (2012) (192)
- A comprehensive three-dimensional radiation treatment planning system. (1988) (191)
- Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy. (1994) (178)
- Prognostic signs and the management of the mycosis fungoides (1973) (172)
- Measurement of patient positioning errors in three-dimensional conformal radiotherapy of the prostate. (1997) (170)
- Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. (2003) (165)
- Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. (2005) (163)
- Intensity-modulated radiotherapy. (2002) (154)
- Long‐term effects of external radiation on the pituitary and thyroid glands (1976) (153)
- Recurrence rates following radiation therapy of nodular and diffuse malignant lymphomas. (1973) (149)
- The treatment of single brain metastasis from non‐oat cell lung: Carcinoma surgery and radiation. Versus radiation therapy alone (1986) (147)
- The biological basis for conformal three-dimensional radiation therapy. (1991) (143)
- Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer. (1993) (138)
- Non‐Hodgkin's lymphomas. V. Results of radiotherapy (1973) (138)
- Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer. (2008) (135)
- Intensity-modulated radiation therapy for prostate cancer. (2002) (134)
- Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease (1975) (134)
- A method of incorporating organ motion uncertainties into three-dimensional conformal treatment plans. (1996) (134)
- Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx. (1991) (132)
- Treatment-related symptoms during the first year following transperineal 125I prostate implantation. (1994) (129)
- The use of a multi-leaf collimator for conformal radiotherapy of carcinomas of the prostate and nasopharynx. (1993) (128)
- Optimization of intensity-modulated 3D conformal treatment plans based on biological indices. (1995) (123)
- Staging laparotomies in unselected previously untreated patients with non‐Hodgkin's lymphomas (1973) (122)
- Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease. (1993) (121)
- The potential and limitations of the inverse radiotherapy technique. (1994) (120)
- IMRT of large fields: whole-abdomen irradiation. (2001) (118)
- Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: interim report of a phase 1 dose-escalation study. (1994) (117)
- The effect of setup uncertainties on the treatment of nasopharynx cancer. (1993) (116)
- Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test. (1976) (116)
- Clinical staging for cutaneous T-cell lymphoma. (1984) (112)
- Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer. (2005) (108)
- Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma. (1994) (106)
- The rationale for curative radiotherapy in mycosis fungoides. (1977) (105)
- Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases. (2011) (103)
- Short-term freedom from disease progression after I-125 prostate implantation. (1994) (98)
- Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer. (1995) (97)
- The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate. (1994) (96)
- Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer. (2002) (94)
- Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low‐grade and intermediate‐grade non‐Hodgkin lymphoma. Results of a prospective randomized study (1993) (94)
- Localized carcinoma of the prostate (Stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy (1993) (94)
- Anterior decompression of the spine for metastatic epidural cord compression: A promising avenue of therapy? (1982) (92)
- The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy. (1997) (91)
- Radiation therapy in the management of cutaneous T-cell lymphomas. (1979) (91)
- From IMRT to IGRT: frontierland or neverland? (2006) (88)
- Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data. (2001) (88)
- Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer. (2003) (87)
- Three-dimensional conformal radiotherapy and dose escalation: where do we stand? (1998) (86)
- The coexistence of nodular and diffuse patterns in nodular non‐Hodgkin's lymphomas. Significance and clinicopathologic correlation (1977) (83)
- Modeling the development of metastases from primary and locally recurrent tumors: comparison with a clinical data base for prostatic cancer. (1993) (82)
- Impact of the time interval between surgery and postoperative radiation therapy on locoregional control in advanced head and neck cancer (1990) (81)
- An improved method for computerized tomography-planned transperineal 125iodine prostate implants. (1991) (81)
- Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer. (2000) (80)
- Total-skin electron treatment of mycosis fungoides. (1971) (80)
- The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma. (1995) (79)
- Esthesioneuroblastoma: Is there a role for elective neck treatment? (1991) (79)
- Computerized design of target margins for treatment uncertainties in conformal radiotherapy. (1999) (74)
- Locally advanced prostatic cancer: long-term toxicity outcome after three-dimensional conformal radiation therapy--a dose-escalation study. (1998) (74)
- Spinal epidural tumor in patients with prostate cancer. Clinical and radiographic predictors of response to radiation therapy (1992) (67)
- The long term effects of radiation on T and B lymphocytes in the peripheral blood after regional irradiation (1977) (66)
- Hyperkeratotic and verrucous features of mycosis fungoides. (1977) (65)
- Short-term morbidity from CT-planned transperineal I-125 prostate implants. (1993) (63)
- Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer. (2000) (63)
- Accurate setup of paraspinal patients using a noninvasive patient immobilization cradle and portal imaging. (2005) (61)
- Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group. (1979) (57)
- Non‐Hodgkin's lymphomas of stage III extent. Is total lymphoid irradiation appropriate treatment? (1976) (56)
- A feasibility study of automated inverse treatment planning for cancer of the prostate. (1998) (56)
- Current concepts in cancer: ovary--treatment for stages III and IV. The multimodal approach to the treatment of stage III ovarian carcinoma. (1982) (55)
- External radiotherapy of ovarian cancer: standard approaches and new frontiers. (1975) (54)
- Spinal metastases: From conventional fractionated radiotherapy to single-dose SBRT. (2015) (54)
- Abdominal irradiation in non‐Hodgkin's lymphomas (1976) (53)
- Chemotherapeutic and surgical induction of pathological complete remission and whole abdominal irradiation for consolidation does not enhance the cure of stage III ovarian carcinoma. (1988) (52)
- Three-dimensional photon treatment planning for carcinoma of the nasopharynx. (1991) (52)
- Three dimensional conformal treatment planning with multileaf collimators. (1995) (51)
- Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer. (2002) (51)
- Fluoroscopic visualization of the prostatic urethra to guide transperineal prostate implantation. (1994) (50)
- 125iodine reimplantation for locally progressive prostatic carcinoma. (1990) (50)
- Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera. (1976) (48)
- Variation in prostate position: Quantitation and implications for three-dimensional conformal radiation therapy (1993) (48)
- Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. (1999) (46)
- Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy. (2003) (46)
- Patterns of presentation and relapse in the non-Hodgkin's lymphomata. (1975) (45)
- The treatment of mycosis fungoides. Adjuvant topical mechlorethamine after electron beam therapy (1977) (45)
- Reduced incidence of the somnolence syndrome in leukemic children with steroid coverage during prophylactic cranial radiation therapy. Results of a pilot study (1989) (44)
- Three-dimensional conformal treatment: a new frontier in radiation therapy. (1991) (43)
- The role of radiation therapy in the control of pain from pancreatic carcinoma. (1988) (42)
- A study of the effects of internal organ motion on dose escalation in conformal prostate treatments. (2003) (41)
- Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models. (2000) (40)
- Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity. (1975) (39)
- The role of lymphography in patients with ovarian cancer (1974) (38)
- Phase III Multi-Center, Prospective, Randomized Trial Comparing Single Dose 24 Gy Radiotherapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer. (2021) (37)
- Timing of lethality from gastrointestinal syndrome in mice revisited. (2009) (37)
- The rationale for curative radiotherapy for ovarian carcinoma. (1975) (36)
- Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease. (1989) (34)
- Image-fusion of MR spectroscopic images for treatment planning of gliomas. (2004) (33)
- Successful chemotherapy of recurrent intracranial germinoma with spinal metastases (1983) (31)
- A reappraisal of the role of prophylactic cranial irradiation in limited small cell lung cancer. (1992) (31)
- Education and Training for Radiation Scientists: Radiation Research Program and American Society of Therapeutic Radiology and Oncology Workshop, Bethesda, Maryland, May 12–14, 2003 (2003) (30)
- Phenotype-Oriented Ablation of Oligometastatic Cancer with Single Dose Radiation Therapy. (2019) (30)
- Acute myocardial infarction with normal coronary arteriogram after mantle field radiation therapy for Hodgkin's disease (1983) (30)
- Prognostic signs and the management of the mycosis fungoides. (1973) (30)
- Safety and Efficacy of Virtual Prostatectomy With Single-Dose Radiotherapy in Patients With Intermediate-Risk Prostate Cancer: Results From the PROSINT Phase 2 Randomized Clinical Trial. (2021) (28)
- Phase I dose escalation study using the deep inspiration breath hold technique to safely increase dose to 81 Gy in the treatment of inoperable non-small cell lung cancer (2000) (28)
- Preliminary results of alternating combination chemotherapy (CT) and hyperfractionated radiotherapy (HART) in advanced rhabdomyosarcoma (RMS). (1988) (28)
- Initial clinical experience with computer-controlled conformal radiotherapy of the prostate using a 50-MeV medical microtron. (1994) (28)
- Topical mechlorethamine therapy for mycosis fungoides (1977) (27)
- Lymphography in mycosis fungoides (1974) (26)
- New wine in an old bottle? Dose escalation under dose-volume constraints: a model of conformal therapy of the prostate. (1996) (26)
- Definitive irradiation for localized non-Hodgkin's lymphoma of breast. (1989) (25)
- Results of a phase I dose escalation study in the treatment of inoperable non-small cell lung cancer (2003) (25)
- Beam characteristics of a new generation 50 MeV racetrack microtron. (1995) (25)
- Clinical and technical aspects of conformal therapy (1993) (24)
- Delayed central nervous system (cns) radiation in childhood cns acute lymphoblastic leukemia results of a pilot trial (1990) (23)
- Results of postoperative megavoltage radiotherapy of malignant surface epithelial tumors of the ovary. (1975) (23)
- Three-dimensional treatment planning considerations for prostate cancer. (1991) (22)
- Megavoltage radiotherapy using water bolus in the treatment of Kaposi's sarcoma. (1986) (20)
- The potential and limitations of the inverse radiotherapy technique (1995) (20)
- Experience with lymphography in patients with mycosis fungoides. (1979) (19)
- Early observations of acute and chronic toxicity & psa response in patients with carcinoma of the prostate treated on a dose escalation study with 3D-CRT (1994) (19)
- Fractionated radiation facilitates repair and functional motor recovery after spinal cord transection in rat (2001) (19)
- 3-D conformal radiotherapy for carcinoma of the prostate. Clinical experience at the Memorial Sloan-Kettering Cancer Center. (1996) (19)
- Conformal three dimensional treatment planning may improve the therapeutic ratio of high dose radiation therapy for lung cancer (1991) (19)
- Combined modality treatment for stage III ovarian carcinoma. (1985) (18)
- Comparison of kilovoltage cone-beam computed tomography with megavoltage projection pairs for paraspinal radiosurgery patient alignment and position verification. (2008) (17)
- 3-D conformal radiation therapy for non-small cell lung carcinoma. Clinical experience at the Memorial Sloan-Kettering Cancer Center. (1996) (17)
- Diaphragmatic treatment in ovarian carcinoma: a new radiotherapeutic technique. (1977) (16)
- Ten-year results of dose escalation with 3-dimensional conformal radiotherapy for patients with clinically localized prostate cancer (2003) (16)
- Interstitial Irradiation in Prostatic Cancer: Report of 10-Year Results (1987) (16)
- E-rosette inhibiting substance in Hodgkin's disease spleen extracts. (1977) (16)
- 1008 Correlation of DVH and treatment planning variables with late rectal bleeding after 3D-CRT of prostate cancer: What is the best way to define the rectal length and volume? (1999) (15)
- Improved survival of poor prognosis diffuse histiocytic (large cell) lymphoma managed with sequential induction chemotherapy, "boost" radiation therapy, and autologous bone marrow transplantation. (1988) (15)
- Twice daily thoracic irradiation for limited small cell lung cancer. (1991) (14)
- Conformal radiation treatment: a critical appraisal. (1995) (14)
- Radiographic manifestations of carcinoma of the cervix and complications of its treatment. (1974) (13)
- Serum transcobalamin II levels in breast carcinoma patients. (1981) (13)
- Local control is associated with decreased distant failure in early stage carcinoma of the prostate (1989) (13)
- Tumor control probability for permanent implants in prostate. (1993) (13)
- Conjecture on the use of high energy electrons for conformal radiotherapy (1992) (13)
- Roentgenologic aspects of Hodgkin's disease: repeat lymphangiography. (1973) (13)
- Target motion mitigation promotes high-precision treatment planning and delivery of extreme hypofractionated prostate cancer radiotherapy: Results from a phase II study. (2020) (12)
- Sex hormone binding globulin (SHBG) in breast cancer: a correlation with obesity but not with estrogen receptor status. (1984) (12)
- An Analysis of Prognostic Factors for Local Control of Malignant Spine Tumors Treated with Spine Radiosurgery (2011) (11)
- Long-Term Implications of a Positive Posttreatment Biopsy in Patients Treated with External Beam Radiotherapy for Clinically Localized Prostate Cancer (2019) (11)
- Direct fluorometric determination of erythrocyte free and zinc protoporphyrins in health and disease. (1985) (10)
- 16 : Long-Term Distant Metastases-Free Survival and Cause-Specific Survival Outcomes After High Dose Conformal Radiotherapy for Clinically Localized Prostate Cancer (2006) (10)
- Observations on the natural history and treatment of recurrent major salivary gland cancer (1990) (10)
- The role of radiation therapy in the management of ovarian carcinoma. (1977) (10)
- The use of port films from multiple projections to determine the spatial distribution of setup errors for prostate cancer patients (1994) (10)
- Is cranial radiation necessary for CNS prophylaxis in pediatric NHL? (1987) (10)
- Roentgenologic Aspects of Hodgkin's Disease: (1973) (10)
- Acute morbidity and PSA response in patients with carcinoma of the prostate treated with three dimensional conformal radiation therapy (1992) (10)
- 59 : Intensity Modulated Radiation Therapy to a Dose of 86.4 Gy for Localized Prostate Cancer: Toxicity Data and Preliminary Biochemical Outcomes (2006) (9)
- The evolving role of external beam radiotherapy in localized prostate cancer. (2019) (9)
- Impact of Transurethral Resection on the Long-Term Outcome of Patients with Prostatic Carcinoma (1993) (9)
- The Impact of Local Tumor Control on the Outcome in Human Cancer (1993) (9)
- 112 The deep inspiration breath[ hold technique for the treatment of lung cancer: The first 200 treatments (1999) (9)
- Initial clinical experience with computer-controlled conformal radiotherapy using the MM50 microtron (1993) (9)
- The role of total skin irradiation with electrons in the management of mycosis fungoides. (1977) (9)
- Final report of the 70.2 GY and 75.6 GY dose levels of a phase I dose escalation study using three dimensional conformal radiotherapy in the treatment of inoperable lung cancer (1998) (9)
- Poster ViewingAcute Toxicity Following Single-Dose Radiation Therapy in the Management of Intermediate Risk Prostate Cancer: Results from a Phase 2 Randomized Trial (2017) (8)
- [Small-cell lung cancer]. (1984) (8)
- 76 Impact of radiation dose on achieving nadir PSA levels after 3-dimensional conformal radiotherapy for patients with localized prostate cancer (1996) (8)
- Rectal bleeding after conformal radiotherapy of prostate cancer and dose volume histograms (1998) (8)
- Conformal Avoidance of Normal Organs at Risk by Perfusion Modulated Dose Sculpting in Tumor Single Dose Radiotherapy. (2020) (8)
- Inclusion of systematic setup uncertainties in treatment plans (1994) (8)
- Incorporation of organ motion uncertainties into 3d prostate treatment plans (1994) (7)
- Repeat Lymphography in Non-Hodgkin's Lymphoma. (1975) (7)
- The effects of ionizing irradiation on production of thromboxane and prostacyclin by the isolated perfused rat kidney. (1988) (7)
- 78 The potential of optimized intensity modulation to escalate prostate dose to 86.4 GY (1996) (7)
- Single-dose radiotherapy (SDRT) in the management of intermediate risk prostate cancer: Early results from a phase II randomized trial. (2018) (7)
- Clinical characteristics of patients with epidermoid carcinoma of the upper aerodigestive tract who develop second malignant tumors. (1992) (7)
- A new device to stabilize templates for transperineal I-125 implants. (1991) (7)
- Reproducibility and accuracy of a target motion mitigation technique for dose-escalated prostate stereotactic body radiotherapy. (2021) (6)
- Radiation therapy for locally advanced breast cancer: prognostic factors and complication rate. (1990) (6)
- The effect of postoperative radiotherapy on the feasibility of optimal dose adjuvant CMF chemotherapy in stage II breast carcinoma. (1983) (6)
- The current role of radiotherapy in the management of ovarian cancer. (1992) (5)
- Long-term outcome of high dose intensity modulated radiotherapy for clinically localized prostate cancer (2004) (5)
- Cerebral necrosis following neutron radiation of an extracranial tumor (1988) (5)
- Thromboxane and Prostacyclin Production by Irradiated and Perfused Rat Kidney (1987) (5)
- Single Fraction Image Guided Intensity Modulated Radiation Therapy (IG IMRT) for Metastatic Lesions of the Spinal Column (2005) (5)
- SECTION 4 Cancer of the Prostate (2005) (5)
- Phase III Multi-Center, Prospective Randomized Trial Comparing High Dose Single Fraction Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Human Cancer (2018) (4)
- 29 Mixed modality intensity-modulated radiation therapy treatment planning for intracranial lesions (1997) (4)
- Elevation of erythrocyte zinc- and free protoporphyrins with metastatic spread in cancer patients. (1986) (4)
- Forging New Strategies in the Cure of Human Oligometastatic Cancer. (2020) (4)
- PSA response after transperineal I-125 prostate implantation (1993) (4)
- 46 Improved conformality and reduced toxicity with high-dose intensity modulated radiation therapy (IMRT) for patients with prostate cancer (1999) (4)
- Correlation of long-term biochemical outcome with post-treatment biopsy results for patients treated with 3-dimensional conformal radiotherapy for prostate cancer (2004) (3)
- 1043 Dose escalation for maxillary sinus cancer using intensity-modulated radiation therapy (IMRT) (1997) (3)
- NEW CONCEPTS IN THE MANAGEMENT OF MYCOSIS FUNGOIDES (1974) (3)
- Post-treatment F-18 FDG-PET Standardized Uptake Value (SUV) Predicts Local Control Following High- dose Single-fraction IGRT (2009) (3)
- Advances in translational radiation oncology: from molecular signaling to cancer cure. (2004) (3)
- Predicting the metastatic potential of prostatic cancer: Is lymph node staging necessary? (1987) (3)
- 50 – Cancer of the Ovary (2010) (3)
- Serum transcobalamin levels as an early indicator of bone marrow engraftment following transplantation (1983) (2)
- Three-dimensional conformal radiation therapy: recent developments and prospects for the future. (1995) (2)
- Incorporation of multileaf collimation in clinical 3D conformal treatment planning (1992) (2)
- Outcome of clinical stage T1c prostate cancer treated with 3-dimensional conformal radiotherapy (1998) (2)
- Short-term results of computerized tomographic-based transperineal iodine-125 prostate implantation (1993) (2)
- Does local-regional control affect distant metastatic spread in squamous cell carcinoma of the head and neck? Results of an rtog analysis. (1990) (2)
- Predictors o f B iochemical O utcome W ith S alvage C onformal Radiotherapy A fter R adical P rostatectomy f or P rostate C ancer (2003) (2)
- Risk stratification predicts biochemical outcome after salvage post-prostatectomy three-dimensional conformal radiation therapy (2001) (2)
- Predictors of post-treatment prostatic biopsy outcome after 3-dimensional conformal radiotherapy for patients with clinically localized prostate cancer (2000) (2)
- Urethra Sparing With Target Motion Mitigation in Dose-Escalated Extreme Hypofractionated Prostate Cancer Radiotherapy: 7-Year Results From a Phase II Study (2022) (2)
- Early PSA density kinetics predicts biochemical and local failure following extreme hypofractionated radiotherapy in intermediate-risk prostate cancer. (2022) (1)
- New concepts in the management of mycosis fungoides. (1974) (1)
- Prognostic factors for maintained efficacy of Sildenafil citrate in the management of erectile dysfunction after radiotherapy for prostate cancer (2003) (1)
- Computer-Controlled 3D Conformal Radiation Therapy (1995) (1)
- Prognostic significance of changes in serum transcobalamin levels in cancer patients with chemotherapy-induced granulocytopenia. (1983) (1)
- Diagnosis and Treatment of Mycosis Fungoides (1974) (1)
- Tantalum, a new contrast agent for tracheobronchography. (1974) (1)
- PO-0927: Minimizing intra-fractional prostate motion during hypofractionated radiotherapy using beacon transponders (2015) (1)
- Phase I study of the combination of iv mitomycin and oral metronidazole. (1984) (1)
- CLINICAL UROLOGY: Letters to the EditorRE: HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED CANCER (2001) (1)
- 1012 Quantification of variation in organ position and volume during conformal radiotherapy of the prostate (1996) (1)
- 100 Risk factors for impotence in patients with carcinoma of the prostate treated with three-dimensional conformal radiation therapy (1995) (1)
- 124 Planning, delivery, and quality assurance of treatment with dynamic multileaf collimator for prostate: A strategy for large scale implementation (1996) (1)
- Questioning current policies for the curative management of ovarian carcinoma. (1988) (1)
- IMPROVED OUTCOME WITH HIGH DOSE 3-DIMENSIONAL CONFORMAL RADIOTHERAPY: RESULTS OF 1050 PATIENTS TREATED FOR LOCALIZED PROSTATE CANCER (1999) (1)
- PV-0621: Single-Dose SBRT for Intermediate-risk prostate cancer: Early results from a randomized trial (2018) (1)
- Pitfalls in deducing radiobiological parameters for tumors from clinical data: a study of biopsy outcome after three-dimensional conformal radiation therapy (3D-CRT) of prostate cancer☆ (2000) (1)
- Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and distant therapy (1992) (1)
- Early Posttreatment PET SUVmax Predicts Local Control Following Single Dose Radiation Therapy (SDRT) in Oligometastasis (2015) (1)
- [A marihuana component for nausea and vomiting induced by chemo- and radiotherapy]. (1983) (1)
- PO-0844 Target motion mitigation and dose painting in prostate cancer SBRT: results from a Phase II study (2019) (1)
- Preliminary results of alternating intensive multiagent chemotherapy (CT) and hyperfractionated radiotherapy (hart) in advanced rhabdomyosarcoma (rms): the memorial hospital (MSKCC) experience (1987) (1)
- 173 Single fraction image guided intensity modulated radiotherapy for paraspinal metastases (2006) (0)
- 325Conformal therapy of prostate cancer using intensity-modulated x-rays designed by the inverse technique and produced with dynamic multileaf collimation (1996) (0)
- Sphingolipid Signaling With High Single-Dose SBRT/SRS (2014) (0)
- An in vivo tissue-model of mitotic cell death and EGFR-signaling (2003) (0)
- Radiation therapy in carcinoma of the ovary: Indications, technical considerations and results z (1987) (0)
- Treatment of febrile granuloycytopenic cancer patients receiving antineoplastic therapy with a combination of carbenicillin, cefazolin and gentamicin. (1983) (0)
- Single-Dose vs 5-Fraction SBRT For Intermediate-Risk Prostate Cancer: 4-Year Results From A Randomized Trial (2020) (0)
- [Treatment of chondrosarcomas of the extremities with isolated perfusion of radioactive S35]. (1967) (0)
- Positron Emission Tomography−Derived Metrics Predict the Probability of Local Relapse After Oligometastasis-Directed Ablative Radiation Therapy (2022) (0)
- Letter: Diagnosis and treatment of mycosis fungoides. (1974) (0)
- Pretreatment N omogram f or P redicting t he O utcome of T hree-Dimensiona l C onformal R adiotherapy i n Prostate C ancer (2000) (0)
- Book review (2004) (0)
- Continuous course of megavoltage radiotherapy for carcinoma of the prostate. (1988) (0)
- Predictors of late femoral head toxicity after high-dose 3D-conformal radiotherapy and intensity modulated radiotherapy (2002) (0)
- In Reply to Rans et al. (2021) (0)
- A study of the effects of internal organ motion and setup error on dose escalation in conformal prostate treatments (1998) (0)
- Health-related quality of life of salvage prostate reirradiation using stereotactic ablative radiotherapy with urethral-sparing (2022) (0)
- Treatment of Febrile Granulocytopenic Cancer Patients Receiving Antineoplastic Therapy With a Combination of Carbenicillin, Cefazolin and Gentamycin (1984) (0)
- The Biology of Single Dose Radiotherapy (2016) (0)
- Total dose of twice daily thoracic irradiation and the use of concomitant chemotherapy may be important determinants of outcome for limited stage small-cell lung cancer (1990) (0)
- 2136 Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostatic adenocarcinoma (1999) (0)
- Induction chemotherapy with cisplatin and cyclophosphamide and maintenance chemotherapy with doxorubicin and 5-FU in advanced urinary bladder tumors. (1983) (0)
- Morbidity of permanent I-126 transperineal prostate implantation (1993) (0)
- Correlation of PSA with long term outcome in patients treated for prostatic carcinoma (1993) (0)
- Single-Dose Radiotherapy for Prostate Cancer-Lessons Learned From Single-Fraction High-Dose-Rate Brachytherapy-Reply. (2021) (0)
- Combined modality therapy for advanced stage hodgkin's disease: patterns of relapse, prognostic factors and the role of radiation therapy (1990) (0)
- 322Clinical implementation of dynamic multileaf-modulation for intensity-modulated treatments (1996) (0)
- Using logical combinations of structures as a utility for inverse planning (1998) (0)
- Pre-Treatment and Early Post-Radiotherapy PET Metabolic Metrics Predict Probability of Local Relapse in Oligometastases (2019) (0)
- EP-1295: Target motion assessment with beacon transponders during extreme hypofractionated IGRT of the prostate (2014) (0)
- [Intraoperative irradiation for abdominal tumors]. (1984) (0)
- Phase II Prospective Trial to Assess the Feasibility and Efficacy of Dynamic 24Gy Single Dose Ablative Stereotactic Radiation Therapy in Oligometastatic Human Cancer (2018) (0)
- 125 A Monte Carlo approach to the design of target margins for setup errors and organ motion in conformal radiotherapy (1996) (0)
- Adjubant chop chemotherapy following radiotherapy in stage I low and intermediate grade non-hodgkin's lymphoma: Results of a prospective randomized study (1991) (0)
- 29 A new era in radiotherapy (1995) (0)
- 2132 Analysis of biopsy outcome after three-dimensional radiation therapy of prostate cancer using dose distribution variables (1999) (0)
- Conformal radiotherapy for prostate cancer (1999) (0)
- Abrogation of acute and chronic gvhd in adults with aplastic anemia aa treated with t cell depleted marrow transplants (1990) (0)
- Clinical Use of Anchored Electromagnetic Beacon Transponder Tracking During SBRT of Lung Lesions (2015) (0)
- Comparison o f t he 5 -Year O utcome a nd M orbidity of T hree-Dimensiona l C onformal R adiotherapy Versus T ransperineal P ermanent I odine-125 I mplantation for E arly-Stage P rostatic C ancer (1999) (0)
- Phase 1/2 Study of Urethral and Rectal Sparing Following Extreme Hypofractionated (5x9 Gy) Stereotactic Body Radiation Therapy in Prostate Cancer (2016) (0)
- PET-derived Metrics Predict the Probability of Local Relapse After Oligometastasis-Directed Ablative Radiotherapy (2021) (0)
- [Combined chemotherapy in metastatic breast cancer: predictive value of dose levels and performance status]. (1986) (0)
- 119 Use of radiobiological indices to guide dose escalation of the prostate cancer patients (1997) (0)
- DTIC and Actinomycin D with and without C. Parvum Immunotherapy in Advanced Malignant Melanoma (1981) (0)
- Signaling-based apoptosis therapy: Potential for improving the outcome in clinical radiotherapy (1996) (0)
- Treatment of locally advanced breast carcinoma with high-dose external beam supervoltage radiotherapy. (1981) (0)
- Will an enhanced local control with conformal radiation therapy lead to improved treatment outcome (1993) (0)
- Modeling the Development of Métastasesfrom Primary and Locally Recurrent l\imors: Comparison with a Clinical Data Base for Prostatic Cancer1 (2006) (0)
- Chapter 6 – Three-Dimensional and Conformal Treatment Planning (2002) (0)
- Pretreatment N omogram T hat P redicts 5 -Year P robability o f Metastasis F ollowing T hree-Dimensiona l C onformal R adiation Therapy f or L ocalized P rostate C ancer (2003) (0)
- 1048 Parotid gland sparing using inverse planning for radiotherapy of nasopharyngeal carcinomas (1997) (0)
- Total lymphoid irradiation and high-dose chemotherapy followed by autologous bone marrow transplantation for relapsed or refractory Hodgkin's disease: 7-year experience (1992) (0)
- The Impact of Dose upon the Local Control of Solid Tumor Metastases Treated with High-dose Spine Radiosurgery (2009) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Zvi Y. Fuks?
Zvi Y. Fuks is affiliated with the following schools:
